Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
In type 2 diabetes, hyperglycemia, insulin resistance, increased inflammation, and oxidative stress were shown to be associated with the progressive deterioration of beta-cell function and mass. Short-chain fatty acids (SCFAs) are organic fatty acids produced in the distal gut by bacterial fermentat...
Saved in:
Main Authors: | Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, Giorgio Luciano Viviani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/162021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
by: Roberta Sanguineti, et al.
Published: (2014-01-01) -
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
by: Monika Adamczyk-Sowa, et al.
Published: (2017-01-01) -
Research Progress in Short-Chain Fatty Acid Modulation of the Gut-Bone Axis in Bone Metabolism
by: ZHANG Xuan, YANG Xue, LI Xinke, MENG Lu, WANG Jiaqi, ZHENG Nan
Published: (2025-01-01) -
miR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells
by: Roberta Sanguineti, et al.
Published: (2021-01-01) -
Intestinal Short-Chain Fatty Acids in Patients with Bronchial Asthma
by: O. Yu. Zolnikova, et al.
Published: (2019-05-01)